Главная Назад


Авторизация
Идентификатор пользователя / читателя
Пароль (для удалённых пользователей)
 

Вид поиска

Область поиска
в найденном
Найдено в других БД
Формат представления найденных документов:
библиографическое описание краткийполный
Отсортировать найденные документы по:
авторузаглавиюгоду изданиятипу документа
Поисковый запрос: (<.>S=ВОРИКОНАЗОЛ<.>)
Общее количество найденных документов : 214
Показаны документы с 1 по 20
 1-20    21-40   41-60   61-80   81-100   101-120      
1.
A rescue therapy with a combination of caspofungin and liposomal amphotericin B or voriconazole in children with haematological malignancy and refractory invasive fungal infections // Mycoses, 2011. Vol. 54, N 3.-С.234-242

2.
A rescue therapy with a combination of caspofungin and liposomal amphotericin B or voriconazole in children with haematological malignancy and refractory invasive fungal infections // Mycoses, 2011. Vol. 54, N 3.-С.234-242

3.
Activities and ultrastructural effects of antifungal combinations against simulated Candida endocardial vegetations // Antimicrob. Agents and Chemother., 2008. Vol. 52, N 7.-С.2367-2376

4.
Activities of antifungal agents against yeasts and filamentous fungi: Assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing // Antimicrob. Agents and Chemother., 2008. Vol. 52, N 10.-С.3637-3641

5.
Adverse effects of voriconazole: Analysis of the French pharmacovigilance database // Ann. Pharmacother., 2007. Vol. 41, N 5.-С.755-763

6.
Kappe R. Antifungal activity of the new azole UK-109, 496 (voriconazole) // Mycoses, 1999. Vol. 42, Suppl. 2.-С.83-86

7.
Kappe R. Antifungal activity of the new azole UK-109, 496 (voriconazole) // Mycoses, 1999. Vol. 42, Suppl. 2.-С.83-86

8.
Bioavailability and population pharmacokinetics of voriconazole in lung transplant recipients // Antimicrob. Agents and Chemother., 2010. Vol. 54, N 10.-С.4424-4431

9.
Bronchopulmonary disposition of intravenous voriconazole and anidulafungin given in combination to healthy adults // Antimicrob. Agents and Chemother., 2009. Vol. 53, N 12.-С.5102-5107

10.
Bronchopulmonary disposition of intravenous voriconazole and anidulafungin given in combination to healthy adults // Antimicrob. Agents and Chemother., 2009. Vol. 53, N 12.-С.5102-5107

11.
Bernhardt Changes in Candida albicans colonization and morphology under influence of voriconazole // Mycoses, 2003. Vol. 46, N 9-10.-С.370-374

12.
Howard Clinical application of voriconazole concentrations in the treatment of invasive aspergillosis // Ann. Pharmacother., 2008. Vol. 42, N 12.-С.1859-1864

13.
Howard Clinical application of voriconazole concentrations in the treatment of invasive aspergillosis // Ann. Pharmacother., 2008. Vol. 42, N 12.-С.1859-1864

14.
Clinical isolates of Aspergillus species remain fully susceptible to voriconazole in the post-voriconazole era // Antimicrob. Agents and Chemother., 2008. Vol. 52, N 9.-С.3444-3446

15.
Kauffman Carol A. Colorimetric method for susceptibility testing of voriconazole and other triazoles against Candida species // Mycoses, 1999. Vol. 42, N 9-10.-С.539-542

16.
Kauffman Carol A. Colorimetric method for susceptibility testing of voriconazole and other triazoles against Candida species // Mycoses, 1999. Vol. 42, N 9-10.-С.539-542

17.
Combination efficacy of voriconazole and amphotericin B in the experimental disease in immunodeficient mice caused by fluconazole-resistant Cryptococcus neoformans // Mycopathologia, 2011. Vol. 171, N 4.-С.261-266

18.
Combination efficacy of voriconazole and amphotericin B in the experimental disease in immunodeficient mice caused by fluconazole-resistant Cryptococcus neoformans // Mycopathologia, 2011. Vol. 171, N 4.-С.261-266

19.
Combination efficacy of voriconazole and amphotericin B in the experimental disease in immunodeficient mice caused by fluconazole-resistant Cryptococcus neoformans // Mycopathologia, 2011. Vol. 171, N 4.-С.261-266

20.
Combination therapy in treatment of experimental pulmonary aspergillosis: In vitro and in vivo correlations of the concentration - and dose-dependent interactions between anidulafungin and voriconazole by bliss independence drug interaction analysis // Antimicrob. Agents and Chemother., 2009. Vol. 53, N 6.-С.2382-2391

 1-20    21-40   41-60   61-80   81-100   101-120      
 




© Международная Ассоциация пользователей и разработчиков электронных библиотек и новых информационных технологий
(Ассоциация ЭБНИТ)